In an indication of how much compounding pharmacies have taken advantage of the absence of regulatory oversight, a government inspection of a facility this week led to yet another product recall.
It has been months since public health authorities registered another fatality related to the tragic fungal meningitis outbreak traced to a contaminated compounding pharmacy last fall. Two people died in the last month alone, bringing the total national fatality count to 51.
Less than a week after we last covered the national fungal meningitis outbreak, the death roll has risen to from 19 to 23 people and more than 300 other victims are sick from the contaminated steroids. Our recent post on the outbreak discussed how a sterilization failure could have contaminated the products and new information suggests that this may have indeed played a role.
A Louisiana judge has set a preliminary court date for the pending lawsuits against drug giant Takeda Pharmaceuticals. The defective drug lawsuits are in regards to Takeda's number one diabetes drug, Actos, which is believed to carry an increased risk of bladder cancer.